Literature DB >> 20697556

The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months.

Carlos del Rio1, Jeannette Guarner.   

Abstract

The present review describes how the first influenza pandemic of the XXI century occurred, the characteristics of the virus that produced it, its epidemiology, clinical and pathological presentation, and the treatment and prevention methods that have been instituted. The lessons that have been learned in the first 6 months of the pandemic include: 1) predictions were not fulfilled (it was not an avian virus but a swine virus that caused the pandemic, it started in the American continent not in Asia), 2) international cooperation was critical, 3) mass media played a key role communicating to the public and health care professionals about this evolving, and 4) preparedness plans were very important to confront the pandemic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697556      PMCID: PMC2917128     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  33 in total

1.  Oseltamivir resistance during treatment of influenza A (H5N1) infection.

Authors:  Menno D de Jong; Tan Thanh Tran; Huu Khanh Truong; Minh Hien Vo; Gavin J D Smith; Vinh Chau Nguyen; Van Cam Bach; Tu Qui Phan; Quang Ha Do; Yi Guan; J S Malik Peiris; Tinh Hien Tran; Jeremy Farrar
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness.

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

3.  Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-06-05       Impact factor: 17.586

4.  Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-04-24       Impact factor: 17.586

5.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

6.  Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-22       Impact factor: 17.586

7.  Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-10-02       Impact factor: 17.586

8.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977.

Authors:  L B Schonberger; D J Bregman; J Z Sullivan-Bolyai; R A Keenlyside; D W Ziegler; H F Retailliau; D L Eddins; J A Bryan
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897

9.  Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.

Authors:  Nila J Dharan; Larisa V Gubareva; John J Meyer; Margaret Okomo-Adhiambo; Reginald C McClinton; Steven A Marshall; Kirsten St George; Scott Epperson; Lynnette Brammer; Alexander I Klimov; Joseph S Bresee; Alicia M Fry
Journal:  JAMA       Date:  2009-03-02       Impact factor: 56.272

10.  Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome.

Authors:  Wanna Hanshaoworakul; James Mark Simmerman; Ubolrat Narueponjirakul; Wiwan Sanasuttipun; Vivek Shinde; Suchada Kaewchana; Darin Areechokechai; Jens Levy; Kumnuan Ungchusak
Journal:  PLoS One       Date:  2009-06-25       Impact factor: 3.240

View more
  8 in total

1.  A Zoonotic Adenoviral Human Pathogen Emerged through Genomic Recombination among Human and Nonhuman Simian Hosts.

Authors:  Shoaleh Dehghan; Jason Seto; Elizabeth B Liu; Ashrafali M Ismail; Ramana Madupu; Albert Heim; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

2.  Influenza A/H1N1 2009 pandemic and respiratory virus infections, Beijing, 2009-2010.

Authors:  Yaowu Yang; Zhong Wang; Lili Ren; Wei Wang; Guy Vernet; Gláucia Paranhos-Baccalà; Qi Jin; Jianwei Wang
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

3.  Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.

Authors:  Rongmao Zhao; Shujuan Cui; Li Guo; Chao Wu; Richard Gonzalez; Gláucia Paranhos-Baccalà; Guy Vernet; Jianwei Wang; Tao Hung
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

4.  Mitigating effects of vaccination on influenza outbreaks given constraints in stockpile size and daily administration capacity.

Authors:  Maytee Cruz-Aponte; Erin C McKiernan; Marco A Herrera-Valdez
Journal:  BMC Infect Dis       Date:  2011-08-01       Impact factor: 3.090

5.  Analysis of severe human adenovirus infection outbreak in Guangdong Province, southern China in 2019.

Authors:  Wenkuan Liu; Shuyan Qiu; Li Zhang; Hongkai Wu; Xingui Tian; Xiao Li; Duo Xu; Jing Dai; Shujun Gu; Qian Liu; Dehui Chen; Rong Zhou
Journal:  Virol Sin       Date:  2022-01-17       Impact factor: 6.947

6.  A universal influenza A and B duplex real-time RT-PCR assay.

Authors:  Hong Kai Lee; Tze Ping Loh; Chun Kiat Lee; Julian Wei-Tze Tang; Lily Chiu; Evelyn Siew-Chuan Koay
Journal:  J Med Virol       Date:  2012-10       Impact factor: 2.327

7.  The Impact of the COVID-19 "Infodemic" on Well-Being: A Cross-Sectional Study.

Authors:  Iffat Elbarazi; Basema Saddik; Michal Grivna; Faisal Aziz; Deena Elsori; Emmanuel Stip; Enes Bendak
Journal:  J Multidiscip Healthc       Date:  2022-02-22

8.  In situ molecular identification of the influenza A (H1N1) 2009 Neuraminidase in patients with severe and fatal infections during a pandemic in Mexico City.

Authors:  Rodolfo Ocadiz-Delgado; Martha Estela Albino-Sanchez; Enrique Garcia-Villa; Maria Guadalupe Aguilar-Gonzalez; Carlos Cabello; Dora Rosete; Fidencio Mejia; Maria Eugenia Manjarrez-Zavala; Carmen Ondarza-Aguilera; Rosa Ma Rivera-Rosales; Patricio Gariglio
Journal:  BMC Infect Dis       Date:  2013-01-18       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.